Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection

PLoS Neglected Tropical Diseases

Volumn 5, Issue 3, 2011, Pages

  Pissetti, Cristina Wide ^a   Correia, Dalmo ^a   de Oliveira, Rafael Faria ^a   Llaguno, Maurício Manoel ^a   Balarin, Marly Aparecida Spadotto ^a   Silva Grecco, Roseane Lopes ^a   Rodrigues Jr , Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CD8+ T LYMPHOCYTE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MACROPHAGE; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOGENICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMA CRUZI;

ADULT; AGED; AGED, 80 AND OVER; CHAGAS DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953767552     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000976     Document Type: Article

References (44)

1. Schofield CJ, Jannin J, Salvatella R, (2006) The future of Chagas disease control. Trends Parasitol 22: 582-588.
2. Rassi A Jr, Rassi A, Marin-Neto JA, (2010) Chagas disease. Lancet 375: 1388-1402.
3. Andrade ZA, (1958) Anatomia patológica da doença de Chagas. Rev Goiana Med 04: 103-119.
4. Prata A, (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
5. Andrade LO, Machado CRS, Chiari E, Pena SDJ, Macedo AM, (2002) Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations. Exp Parasitol 100: 269-275.
6. Alter A, Alcaïs A, Abel L, Schurr E, (2008) Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet 123: 227-235.
7. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, et al. (1985) Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 13: 6361-6373.
8. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, et al. (1987) Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 165: 1581-1594.
9. Tarleton RL, (1988) Tumor necrosis factor [cachectin] production during experimental Chagas' disease. Clin. Exp Immunol 73: 186-190.
10. Vespa GNR, Cunha FQ, Silva JS, (1994) Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 62: 5177-5182.
11. Lima ECS, Garcia I, Vicentelli MH, Vassali P, Minoprio P, (1997) Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun 65: 457-465.
12. Machado FS, Martins GA, Aliberti JCS, Mestriner FLAC, Cunha FQ, et al. (2000) Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102: 3003-3008.
13. Reis DD, Jones EM, Tostes S, Lopes ER, Gazzinelli G, et al. (1993) Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637-644.
14. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW, (1992) Single base polymorphism in the human tumor necrosis factor alpha [TNFalphalpha] gene detectable by NcoI restriction of PCR product. Hum Mol Genet 01: 353.
15. D'Alfonso S, Richiardi PM, (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150-154.
16. Brinkman BMN, Huizinga TWJ, Kurban SS, Van Der Velde EA, Schreuder GM, et al. (1997) Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36: 516-521.
17. Höhler T, Kruger A, Schneider PM, Schopf RE, Knop J, et al. (1997) A TNFalphalpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 109: 562-565.
18. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, et al. (2003) IL-10 and TNFalphalpha polymorphisms and the recovery from HCV infection. Hum Immunol 64: 674-680.
19. Beraún Y, Nieto A, Collado MD, Gonzáles A, Martín J, (1998) Polymorphisms at tumor necrosis factor [TNF] loci are not associated with Chagas' disease. Tissue Antigens 52: 81-83.
20. Rodríguez-Pérez JM, Cruz-Robles D, Hernández-Pacheco G, Pérez-Hernández N, Murguía LE, et al. (2005) Tumor necrosis factoralphalpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 98: 97-102.
21. Drigo SA, Cunha-Neto E, Ianni B, Cardoso MRA, Braga PE, et al. (2006) TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 8: 598-603.
22. Drigo SA, Cunha-Neto E, Ianni B, Mady C, Faé KC, et al. (2007) Lack of association of tumor necrosis factoralphalpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 108: 109-11.
23. Vinhaes MC, Dias JCP, (2000) Chagas disease in Brazil. Cad Saude Publica 16 (Suppl 2): 7-12.
24. Villela MM, Souza JMB, Melo VP, Dias JCP, (2009) Avaliação do Programa de Controle da Doença de Chagas em relação à prevalência de Panstrongylus megistus na região centro-oeste do Estado de Minas Gerais, Brasil. Cad Saude Publica 25: 907-917.
25. Silva-Grecco RL, Balarin MAS, Correia D, Prata A, Rodrigues V, (2010) Familial analysis of seropositivity to Trypanosoma cruzi and of clinical forms of Chagas disease. Am J Trop Med Hyg 82: 45-48.
26. I Reunião de Pesquisa Aplicada em Doença de Chagas (1985) Validade do conceito de forma indeterminada de doença de Chagas. Rev Soc Bras Med Trop 18: 46.
27. Consenso brasileiro em doença de Chagas (2005) Rev Soc Bras Med Trop 38 (supl. 3): 7-29.
28. The Criteria Committee of The New York Heart Association (1994) The Physiologic Cardiac Diagnosis. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels Boston: Little, Brown and Company pp. 174-252.
29. Ferreira RC, Ianni BM, Abel LCJ, Buck P, Mady C, Kalil J, et al. (2003) Increased Plasma Levels of Tumor Necrosis Factor-alpha in Asymptomatic/"Indeterminate" and Chagas Disease Cardiomyopathy Patients. Mem Inst Oswaldo Cruz 98: 407-411.
30. Talvani A, Rocha MOC, Barcelos LS, Gomes YM, Ribeiro AL, et al. (2004) Elevated Concentrations of CCL2 and Tumor Necrosis Factor-alpha in Chagasic Cardiomyopathy. Clin Infect Dis 38: 943-950.
31. Gonçalves JGF, Silva VJD, Borges MCC, Prata A, Correia D, (2009) Mortality indicators among chronic Chagas patients living in an endemic area. Int J Cardiol 30.
32. Rodrigues V, Agrelli GS, Leon SC, Teixeira DNS, Tostes S, et al. (2008) Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect 10: 29-37.
33. Pissetti CW, Correia D, Braga TB, Faria GEL, Oliveira RF, et al. (2009) Association between the plasma levels of TNF-α, IFN-γ, IL-10, nitric oxide and specific IgG isotypes in the clinical forms of chronic Chagas disease. Rev Soc Bras Med Trop 42: 425-430.
34. Wanidworanun C, Strober W, (1993) Predominant role of tumor necrosis factor-alphain human monocyte IL-10 synthesis. J Immunol 151: 6853-6861.
35. Bilate AM, Salemi VM, Ramires FJ, de Brito T, Russo M, et al. (2007) TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 9: 1104-1113.
36. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OSM, et al. (1997) Scarring trachoma is associated with polymorphisms in the tumor necrosis factor alpha [TNF-alpha] gene promoter and with elevated TNFalpha levels in tear fluid. Infect Immun 65: 1003-1006.
37. Vanderborght PR, Matos HJ, Salles AM, Vasconcellos SE, Silva-Filho VF, et al. (2004) Single nucleotide polymorphisms (SNPs) at-238 and-308 positions in the TNFalphalpha promoter: clinical and bacteriological evaluation in leprosy. Int J Lepr 72: 143-148.
38. Bouma G, Crusius JBA, Pool MO, Kolkman JJ, Von Blomberg BME, et al. (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43: 456-463.
39. Kroeger KM, Carville KS, Abraham LJ, (1997) The-308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol 34: 391-399.
40. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Immunology 94: 3195-3199.
41. Fong CLW, Siddiqui AH, Mark DF, (1994) Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucleic Acids Res 22: 1108-1114.
42. Bayley JP, Rooij H, van den Elsen PJ, Huizinga TWJ, Verweij CL, (2001) Functional analysis of linker-scan mutants spanning the-376,-308,-244, and-238 polymorphic sites of the TNFalphalpha promoter. Cytokine 14: 316-323.
43. Kovacvovics-Bankowski M, Clark K, Benacerraf B, Rock KL, (1993) Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90: 4942-4946.
44. Van Voorhis WC, (1992) Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J Immunol 148: 239-248.